Latham & Watkins LLP

Acting on its own as well as frequently in collaboration with lawyers on the mainland, Latham & Watkins LLP handles a significant volume of IPOs and follow on offerings for underwriters and issuers, both in Hong Kong and the US. Although the firm’s versatile practice is comfortable handing transactions across a wide range of industry sectors, under the guidance of Cathy Yeung  it has, in recent years, been particularly active handling  issuances in the TMT, life sciences and new economy sectors. As well as transactional work the team has been involved in a consultative role on the development of the SPAC regime and pre-revenue biotech companies, and has continued to assist regulators in applying the nascent listing regimes. Benjamin Su is central to much of the firm’s work in the TMT space and has developed excellent ties with both Chinese issuers and international underwriters.